CASI Pharmaceuticals, Inc (CASI) Stock Price

0.81 ▼ -0.0215 (-2.59%)
Open: 0.8789 Vol: 8.32K Day's range: 0.81 - 0.8789 Dec 19, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CASI Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.88▼ 0.88▼ 0.88▼ 0.85▼ 0.98▼
MA10 0.90▼ 0.90▼ 0.90▼ 0.87▼ 1.23▼
MA20 0.91▼ 0.89▼ 0.89▼ 0.95▼ 1.63▼
MA50 0.92▼ 1.00▼ 1.05▼ 1.28▼ 1.84▼
MA100 1.09▼ 1.22▼ 1.30▼ 1.62▼ 3.33▼
MA200 1.37▼ 1.53▼ 1.52▼ 1.72▼ 3.38▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.006▼ 0.004▲ 0.009▲ 0.009▲ -0.068▼
RSI 32.655▼ 35.938▼ 36.724▼ 28.903▼ 32.181▼
STOCH 39.408     41.873     50.711     17.378▼ 4.191▼
WILL %R -100.000▼ -100.000▼ -76.312▼ -96.919▼ -99.396▼
CCI -200.393▼ -201.061▼ -71.607     -105.785▼ -121.189▼
Latest Filters Detected On CASI
▼ RSI&STOCH $CASI Oversold RSI + Stochastic Set Alert
▼ RSI $CASI RSI(14) Crossed Below 30 Set Alert
▲ GAP $CASI Open Gap Up %5 Set Alert
▲ GAP $CASI Open Gap Up %3 Set Alert
▲ GAP $CASI Open Gap Up %2 Set Alert
CDL $CASI Marubozu Candlestick Pattern Detected Set Alert
CASI Pharmaceuticals, Inc News
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing
Thursday, December 11, 2025 06:25 AM
Investment to Fund Phase 1 Study in Renal Allograft Antibody-Mediated Rejection (AMR) in China SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 11, 2025 / CASI Pharmaceuticals, Inc. (NASDA ...
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting
Monday, December 08, 2025 05:03 AM
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 8, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potentially ...
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
Friday, November 14, 2025 05:05 AM
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential ...
CASI historical stock data
date open high low close volume
19/12/25 0.8789 0.8789 0.81 0.81 8,317
18/12/25 0.8494 0.8799 0.8315 0.8315 11,696
17/12/25 0.83 0.9279 0.83 0.8421 21,568
16/12/25 0.88 0.93 0.846 0.88 13,325
15/12/25 0.8612 0.9499 0.8612 0.87 27,138
12/12/25 0.935 0.9387 0.8501 0.863 18,172
11/12/25 0.85 0.9665 0.85 0.935 39,216
10/12/25 0.85 0.8569 0.8011 0.8435 25,318
09/12/25 0.9301 0.9699 0.8366 0.8569 72,430
08/12/25 0.9625 1.0499 0.93 0.93 53,197
Quote Details
52wk Low:0.801
52wk High:3.47
Vol:8.32K
Avg Vol(3m):794.6K
1Y Chng:-71.87%
1M Chng:-41.30%
Add to Watch List
More Information
Index US Composite
Market Cap. 12.88M